Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA

Shelbaya, A., Kelton, J. M., Thompson, J., Alvir, J. M., Maculaitis, M. C., & Yang, J. (2021). Real-World Use and Acceptance of Biosimilar Monoclonal Antibodies of Rituximab in Oncology Practice in the USA. Future Oncology, 17(30), 3941–3950. https://doi.org/10.2217/fon-2021-0618
Authors:
Ahmed Shelbaya
John M. Kelton
Jeffrey Thompson
Jose M.J. Alvir
Martine C. Maculaitis
Jingyan Yang
Affiliated Authors:
Ahmed Shelbaya
Jingyan Yang
Columbia Affiliation:
Author Keywords:
biosimilars
chronic lymphocytic leukemia
monoclonal antibodies
non-hodgkin's lymphoma
oncology
rituximab-pvvr
elink
Publication Type:
Article
Unique ID:
10.2217/fon-2021-0618
PMID:
34259584
DOI:
10.2217/fon-2021-0618
Journal:
Future Oncology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record

Record Created: